The functions of bacteriophage proteins;Funkcje białek bakteriofagowych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 65, Issue , 2011, Pages 167-176

  Brzozowska, Ewa ^a   Bazan, Justyna ^b   Gamian, Andrzej ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bacteriophage; Capsid; Phage; Phage adhesions; Phage enzymes; Phage proteins

Indexed keywords

EID: 79958822647     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.936090     Document Type: Review

References (82)

1. Ackermann H.W.: 5500 phages examined in electron microscope. Brief Review. Arch. Virol., 2007; 152: 227-243.
2. Adams M.H.: Bacteriophages. Interscience publishers, INC; New York 1959.
3. Arisaka F.: Assembly and infection process of bacteriophage T4. Chaos, 2005; 15: 1-7. (Pubitemid 43037851)
4. Bartell P.F, Orr T.E., Reese J.F., Imaeda T.: Interaction of Pseudomonas bacteriophage 2 with the slime polysaccharide and lipopolysaccharide of Pseudomonas aeruginosa strain BI. J. Virol., 1971; 8: 311-317.
5. Bennett A.R., Davis F.G., Vlahodimou S., Banks J.G., Betts R.P.: The use of bacteriophage-based systems for the separation and concentration of Salmonella. J. Appl. Microbiol., 1997; 83: 259-265. (Pubitemid 27329772)
6. Benson S.D., Bamford J.K., Bamford D.H., Burnett R.M.: Viral evolution revealed by bacteriophage PRD1 and human adenovirus coat protein structure. Cell, 1999; 98: 825-833. (Pubitemid 29446899)
7. Bernhardt T.G., Wang I.N., Struck D.K., Young R.: A protein antibiotic in the phage Qb virion: diversity in lysis targets. Science, 2001; 292: 2326-2329. (Pubitemid 32568054)
8. Biswas B., Adhya S., Washart P., Paul B., Trostel A.N., Powell B., Carlton R., Merril C.R.: Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun., 2002; 70: 204-210. (Pubitemid 34028619)
9. Borysowski J., Weber-Da̧browska B., Górski A.: Bacteriophage endolysins as a novel class of antibacterial agents. Exp. Biol. Med., 2006; 231: 366-377.
10. Boudko S.P., Strelkov S.V., Engel J., Stetefeld J.: Design and crystal structure of bacteriophage T4 mini - fibritin NCCF. J. Mol. Biol., 2004; 339: 927-935. (Pubitemid 38686354)
11. Cabeen M.T., Jacobs-Wagner C.: Bacterial cell shape. Nat. Rev. Microbiol., 2005; 3: 601-610. (Pubitemid 41052147)
12. Cisło M., Da̧browski M., Weber-Da̧browska B., Woytoń A.: Bacteriophage treatment of suppurative skin infections. Arch. Immunol. Ther. Exp., 1987; 35: 175-183. (Pubitemid 18075973)
13. Clark J.R., March J.B.: Bacteriophages and biotechnology: vaccines, gene therapy and antibacterial. Trends Biotechnol., 2006; 24: 212-218.
14. Da̧browska K., Świtała-Jeleń K., Opolski A., Górski A.: Possible association between phages, Hoc protein and immune system. Arch. Virol., 2006; 151: 209-215. (Pubitemid 43130582)
15. Defives C., Werquin M., Mary P., Hornez J.P.: Roles of exopolysac-charides and lipopolysaccharides in the adsorption of the Siphovirus phage NM8 to Rhizobium meliloti M11S cells. Curr. Microbiol., 1996; 33: 371-376. (Pubitemid 26399207)
16. Demuth J., Neve H., Witzel K.P.: Direct electron microscopy study on the morphological diversity of bacteriophage population in Lake Plußsee. Appl. Environ. Microbiol., 1993; 59: 3378-3384. (Pubitemid 23296457)
17. Fischetti V.A.: Bacteriophage lytic enzymes: novel anti-infectives. Trends Microbiol., 2005; 13: 491-496. (Pubitemid 41317527)
18. Fischetti V.A.: Using phage lytic enzymes to control pathogenic bacteria. BMC Oral Health, 2006; 6(Suppl.1): S16.
19. Garcia J.L., Garcia E., Arraras A., Garcia P., Ronda C., Lopez R.: Cloning, purification, and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysine. J. Virol., 1978; 61: 2573-2580.
20. German G.J., Misra R.: The ToIC protein of Escherichia coli serves a cell-surface receptor for the new characterized TLS bacteriophage. J. Mol. Biol., 2001; 308: 579-585. (Pubitemid 32568462)
21. Górski A., Weber-Da̧browska B.: The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol. Life Sci., 2005; 62: 511-519. (Pubitemid 40386333)
22. Gregoraci G.B.: The biology of bacteriophages. W: Modern bacteriophage biology and biotechnology, red.: G. Wȩgrzyn, Research Signpost, Trivandrum, India, 2006.
23. Hayashi M.N., Hayashi M., Imai M.: Bacteriophage phiX174-specific mRNA synthesis in cells deficient in termination factor rho activity. J. Virol., 1981; 38: 198-207. (Pubitemid 11104799)
24. Häusler T.: Viruses vs. Superbugs: A Solution to the Antibiotics Crisis. Macmillan, 2007.
25. Hewat E.: The bacteriophage PRD1 uses a pseudo-b-propeller to bind to its cellular receptor. Structure, 2003; 11: 239-240. (Pubitemid 36287686)
26. Jawetz E.J., Melnick E., Adelberg A.: Przegla̧d Mikrobiologii Lekarskiej; Państwowy Zakład Wydawnictw Lekarskich; 1991.
27. Kańtoch M.: Badania nad wia̧zaniem wirusów bakteryjnych przez leukocyty. Postȩpy Hig. Med. Dośw., 1958; 12: 637-640.
28. Kańtoch M.: Wybrane zagadnienia z nauki o bakteriofagach. Postȩpy Hig. Med. Dośw., 1956; 10: 47-86.
29. Kańtoch M., Mordarski M.: Wia̧zanie wirusów bakteryjnych przez komórki nowotworowe in vitro. Postȩpy Hig. Med. Dośw., 1958; 12: 191-192.
30. Kańtoch M., Skurski A., Wieczorek Z.: Hamowanie in vitro fagocytozy bakterii za pomoca̧ wirusów bakteryjnych. Postȩpy Hig. Med. Dośw., 1958; 12: 95-96.
31. Kataoka Y., Miyake K., Iijima S.: Coliphage derived sialidase preferentially recognizes nonreducing end of polysialic acid. J. Biosci. Bioeng., 2006; 101: 198-201. (Pubitemid 44354388)
32. Kawaura T., Inagaki M., Karita S., Kato M., Nishikawa S., Kashimura N.: Recognition of receptor lipopolisaccharides by spike G protein of bacteriophage φX174. Biosci. Biotechnol. Biochem., 2000; 64: 1993-1997.
33. Kivelä H.M., Kalkkinen N., Bamford D.H.: Bacteriophage PM2 has a protein capsid surrounding a spherical proteinaceous lipid core. J. Virol., 2002; 76: 8169-8178. (Pubitemid 34809071)
34. Kokocińska I., Rossowski H.: Profilaktyczne zastosowanie bakteriofaga czerwonkowego S. sonnei w domu dziecka. Przegl. Epidemiol., 1974; 28: 497-498.
35. Kostrzewski J., Mulczyk M., Ślopek S.: Próby zapobiegania zakażeniom czerwonkowym w zbiorowiskach ludzi z pomoca̧ wieloważnych bakteriofagów czerwonkowych S. flexneri i S. sonnei. Przegl. Epidemiol., 1974; 28: 483-507.
36. Kostyuchenko A., Chipman P.R, Leiman P.G.: The tail of bacteriophage T4 and its mechanism of contraction. Nat. Struct. Mol. Biol., 2005; 190: 810-813. (Pubitemid 43086256)
37. Kraus J., Geller B.L.: Membrane receptor for prolate phages is not required for infection of Lactococcus lactis by smaller large isometric phages. J. Dairy Sci., 1998; 81: 2329-2333.
38. Kunicki-Goldfinger W.J.: Życie bakterii; PWN; 2005.
39. Kutter E.: Phage therapy: bacteriophages as natural, self-limiting antibiotics. W: Textbook of Natural Medicine, t.1, red.: J. Pizzorno, M. Murray, Churchill Livingstone, Philadelphia, 2005; 1147-1161.
40. Kwan T., Liu J., DuBow M., Gros P., Pelletier J.: Comparative genomic analysis of 18 Pseudomonas aeruginosa bacteriophages. J. Bacteriol., 2006; 188: 1184-1187. (Pubitemid 43146437)
41. Kwiatkowski B., Boschek B., Thiele H., Stirm S.: Endo-N-acetylneuramidase associated with bacteriophage particles. J. Virol., 1982; 43: 697-704.
42. Lehman I.R., Herriott R.M.: The protein coats or "ghosts" of coliphage T2. III. Metabolic studies of Escherichia coli B infected with T2 bacteriophage "ghosts". J. Gen. Physiol., 1958; 41: 1067-1082.
43. Leiman P.G., Battisti A.J., Bowman V.D., Stummeyer K., Mu″hlenhoff M., Gerardy-Schahn R., Scholl D., Molineux I.J.: The structures of bacteriophages K1E and K1-5 explain processive degradation of new host specificities. J. Mol. Biol., 2007; 371: 836-849. (Pubitemid 47087828)
44. Leiman P.G., Kanamaru S., Mesyanzhinov V.V., Arisaka F., Rossmann M.D.: Structure and morphogenesis of bacteriophage T4. Cell Mol. Life Sci., 2003; 60: 2356-2370. (Pubitemid 37487257)
45. Lodowska J., Ziȩba A., Wolny D., Wȩglarz L., Dzierzewicz Z.: Metody derywatyzacji komponentów lipopolisacharydów w ocenie ich struktury chemicznej technikami chromatograficznymi. Postȩpy Hig. Med. Dośw., 2006; 60: 113-128.
46. Loeffler J.M., Djurkovic S., Fischetti V.A.: Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infect. Immun., 2003; 6199-6204. (Pubitemid 37337675)
47. Long G.S., Bryant J.M., Taylor P.W., Luzio J.P.: Complete nucleotide sequence of the gene encoding bacteriophage endosialidase: implications for K1E endosialidase structure and function. Biochem. J., 1995; 309: 543-550.
48. Marvin D.A., Welsh L.C., Symmons M.F., Scot W.R.P.: Molecular structure of fd (f1, M13) filamentous bacteriophage refined with respect to X-ray fibre diffraction and solid-state NMR data supports specific models of phage assembly at the bacterial membrane. J. Mol. Biol., 2006; 355: 294-309. (Pubitemid 41774132)
49. Mesyanzhinow, V.V., Leiman P.G., Kostyuchenko V.A., Kurochkina L.P., Miroshikov K.A., Sykilinda N.N., Shneider M.M.: Molecular architecture of bacteriophage T4. Biochemistry, 2004; 69: 1190-1202. (Pubitemid 40050037)
50. Mesyanzhinov V.V., Robben J., Grymonprez B., Kostyuchenko V.A., Bourkaltseva M.V., Sykilinda N.N., Krylov V.N., Volckaert G.: The genome of bacteriophage φKZ of Pseudomonas aeruginosa. J. Mol. Biol., 2002; 317: 1-19.
51. Mondigler M., Holz T., Heller K.J.: Identification of the receptor-bin-ding regions of pb5 proteins of bacteriophages T5 and BF23. Virology, 1996; 219: 19-28. (Pubitemid 26180380)
52. Morona R., Krämer C., Henning U.: Bacteriophage receptor area of outer membrane protein OmpA of Eschericha coli K-12. J. Bacteriol., 1985; 12: 539-545.
53. Mulczyk M., Ślopek S.: Znaczenie swoistych bakteriofagów w zwalczaniu nosicielstwa pałeczki Shigella sonnei. Przegl. Epidemiol., 1971; 25: 475-476.
54. Nowak-Lipińska K., Libich M.: Profilaktyczne zastosowanie bakteriofaga czerwonkowego Sh. sonnei w Zakładach Dzieciȩcych w Łodzi. Przegl. Epidemiol., 1974; 28: 498-504.
55. Park T., Struck D.K., Deaton J.F., Young R.: Topological dynamics of holins in programmed bacterial lysis. Proc. Natl. Acad. Sci. USA, 2006; 103: 19713-19718. (Pubitemid 46037497)
56. Pederson D.M., Welsh L.C., Marvin D.A., Sampson M., Perham R.N., Yu M., Slater M.R.: The protein capsid of filamentous bacteriophage PH75 from Thermus thermophilus. J. Mol. Biol., 2001; 309: 401-421. (Pubitemid 32553496)
57. Plancon L., Janmot C., le Maire M., Desmadril M., Bonhivers M., Letellier L., Boulanger P.: Characterization of a high-affinity complex between the bacterial outer membrane protein FhuA and the phage T5 protein pb5. J. Mol. Biol., 2002; 318: 557-569. (Pubitemid 34734847)
58. Poot R.A., Tsareva N.V., Boni I.V., van Duin J.: RNA holding kinetics regulates translation of phage MS2 maturation gene. Proc. Natl. Acad. Sci. USA, 1997; 94: 10110-10115. (Pubitemid 27407002)
59. Przondo-Hessek A.: Podstawy lizotypii pałeczek Klebsiella, 1. Rola struktur powierzchniowych pałeczek Klebsiella w wia̧zaniu bakteriofagów. Postȩpy Hig. Med. Dośw., 1985; 39: 264-310.
60. Przondo-Hessek A., Romanowska E.: Lipopolysaccharides of Shigella flexneri 6 as phage receptors. Acta Microbiol. Pol., 1978; 27: 7-102.
61. Przondo-Hessek A., Ślopek S.: Morphology and thermal sensitivity of Klebsiella bacteriophages of the collection of Przondo-Hessek. Arch. Immunol. Ther. Exp., 1967; 15: 547-556.
62. Przondo-Hessek A., Ślopek S.: Typing of Klebsiella bacilli by means of Klebsiella bacteriophages from the collection of Przondo-Hessek. Arch. Immunol. Ther. Exp., 1967; 15: 563-577.
63. Przondo-Hessek A., Ślopek S., Miodońska J: Serologic characterization of the Klebsiella bacteriophages of the Przondo-Hessek collection. Arch. Immunol. Ther. Exp., 1967; 15: 557-562.
64. Riechmann L, Holliger P.: The C-terminal domain of TolA is the coreceptor for filamentous phage infection of E. coli. Cell, 1997; 90: 351-360. (Pubitemid 27329719)
65. Roberts M.D., Martin N.L., Kropinski A.M.: The genome and proteome of coliphage T1. Virology, 2004; 318: 245-266. (Pubitemid 38234278)
66. Rossman M.G, Mesyanzhinov V.V, Arisaka F., Leiman P.G.: The bacteriophage T4 DNA injection machine. Curr. Opin. Struct. Biol., 2004; 14: 171-180. (Pubitemid 38490783)
67. San Martin C., Huiskonen J.T., Bamford J.K., Butcher S.J., Fuller S.D., Bamford D.H., Burnett R.M.: Minor proteins, mobile arms and membrane-capsid interactions in the bacteriophage PRD1 capsid. Nat. Struct. Biol., 2002; 9: 756-763.
68. Schlegel H.G.: Mikrobiologia ogólna, PWN; 1996.
69. Scholl D., Rogers S., Adhya S., Merril C.R.: Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Eschericha coli. J. Virol., 2001; 75: 2509-2515. (Pubitemid 32185014)
70. Serwer P., Hayes S.J., Thomas J.A., Hardies S.C.: Propagating the missing bacteriophages: a large bacteriophage in a new class. J. Virol., 2007; 4: 1-5.
71. Skurnik M., Strauch E.: Phage Therapy: facts and fiction. Int. J. Med. Microbiol., 2006; 296: 5-14. (Pubitemid 43089713)
72. Smith H.W., Huggins M.B.: Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J. Gen. Microbiol., 1982; 128: 307-318. (Pubitemid 12159900)
73. Sutherland I.: Surface carbohydrate of the prokaryotic cell. Academic Press, London, 1977.
74. Szkudlarek D: Profilaktyczne zastosowanie bakteriofaga S. sonnei w domu dziecka. Przegl. Epidemiol., 1974; 28: 505-506.
75. Thiriot S.D., Nevzorov A.A, Zagyanskiy L., Wu C.W., Opella S.J.: Structure of the coat protein in Pf1 bacteriophage determined by solid-state NMR spectroscopy. J. Mol. Biol., 2004; 341: 869-879. (Pubitemid 39118416)
76. Tichaczek-Goska D., Cisowska A.: Wybrane właściwości lipopolisa-charydów bakterii Gram-ujemnych zawieraja̧cych mannan w łańcuchu O-swoistym. Adv. Clin. Exp. Med., 2007; 16: 105-112. (Pubitemid 46487404)
77. Vimr E.R., McCoy R.D., Vollger H.F., Wilkinson N.C., Troy F.A: Use of prokaryotic-derived probes to identify poly(sialic acid) in neonatal neuronal membranes. Proc. Natl. Acad. Sci. USA, 1984; 81: 1971-1975. (Pubitemid 14146588)
78. Vinga, I., Sao-Jones, C., Tavares, P., Santos, M.A.: Bacteriophage entry in the host cell. W: Modern bacteriophage biology and biotechnology, red. G. Wegrzyn, Research Signpost, Trivandrum, India, 2006; 165-205.
79. Wang I.N., Smith D.L., Young R.: Holins: the protein clocks of bacteriophage infections. Annu. Rev. Microbiol., 2000; 54: 799-825.
80. Weinbauer M.: Ecology of prokaryotic viruses. FEMS Microbiol. Rev., 2004; 28: 127-181. (Pubitemid 38510500)
81. Young R.: Bacteriophage lysis: mechanism and regulation. Microbiol. Rev., 1992; 56: 430-481.
82. Zakrzewski K.: Biochemia wirusa bakteryjnego. Postepy Hig. Med. Dosw., 1951; 4: 135-186.